Ginsenoside 3β-O-Glc-DM (C3DM) suppressed glioma tumor growth by downregulating the EGFR/PI3K/AKT/mTOR signaling pathway and modulating the tumor microenvironment.
暂无分享,去创建一个
Yan Li | Jiuming He | Jinling Yang | Mei Tang | Haidong Deng | Kai Zheng
[1] Xianglong Zhang,et al. High-Fat Diet-Induced Fatty Liver Is Associated with Immunosuppressive Response during Sepsis in Mice , 2021, Oxidative medicine and cellular longevity.
[2] Yan Liu,et al. Ginsenoside Rh2 Inhibits Glycolysis through the STAT3/c-MYC Axis in Non-Small-Cell Lung Cancer , 2021, Journal of oncology.
[3] N. Pećina-Šlaus,et al. Integrative cBioPortal Analysis Revealed Molecular Mechanisms That Regulate EGFR-PI3K-AKT-mTOR Pathway in Diffuse Gliomas of the Brain , 2021, Cancers.
[4] P. Wen,et al. The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications. , 2021, Neuro-oncology.
[5] Yunfei Xu,et al. WDR5 facilitates EMT and metastasis of cholangiocarcinoma by increasing HIF-1α accumulation in Myc-dependent and independent pathways. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.
[6] Meilan Zhang,et al. Ginsenoside Compound K Regulates HIF-1α-Mediated Glycolysis Through Bclaf1 to Inhibit the Proliferation of Human Liver Cancer Cells , 2020, Frontiers in Pharmacology.
[7] P. Wen,et al. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.
[8] R. Pérez-Tomás,et al. Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment , 2020, Cancers.
[9] D. Nam,et al. Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts , 2020, Cancers.
[10] Chen Yan,et al. Ginsenoside 3β-O-Glc-DM (C3DM) enhances the antitumor activity of Taxol on Lewis lung cancer by targeting the interleukin-6/Jak2/STAT3 and interleukin-6/AKT signaling pathways , 2020 .
[11] Liang Liu,et al. Novel ginsenoside derivative 20(S)-Rh2E2 suppresses tumor growth and metastasis in vivo and in vitro via intervention of cancer cell energy metabolism , 2020, Cell Death & Disease.
[12] Daidi Fan,et al. Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer. , 2020, Biochemical pharmacology.
[13] H. Engelhard,et al. Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma , 2020, Molecular Neurobiology.
[14] Ruiping Zhang,et al. Evaluation of the tumor-targeting efficiency and intratumor heterogeneity of anticancer drugs using quantitative mass spectrometry imaging , 2020, Theranostics.
[15] Juxiang Chen,et al. Immunotherapy for Malignant Glioma: Current Status and Future Directions. , 2020, Trends in pharmacological sciences.
[16] Zev A. Binder,et al. A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity , 2019, Cell.
[17] J. Manzo-Merino,et al. Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches , 2019, Front. Oncol..
[18] S. Cai,et al. Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer , 2019, Cancer Immunology Research.
[19] J. Rabinowitz,et al. The Tumor Metabolic Microenvironment: Lessons from Lactate. , 2019, Cancer research.
[20] P. Zhu,et al. Construction and optimization of microbial cell factories for sustainable production of bioactive dammarenediol-II glucosides , 2019, Green Chemistry.
[21] Hyunggee Kim,et al. Korean Red ginseng extract inhibits glioblastoma propagation by blocking the Wnt signaling pathway. , 2019, Journal of ethnopharmacology.
[22] Xiaoying Wang,et al. Ginsenoside Rg3 improves cyclophosphamide-induced immunocompetence in Balb/c mice. , 2019, International immunopharmacology.
[23] L. Lynch,et al. Lactate-Mediated Acidification of Tumor Microenvironment Induces Apoptosis of Liver-Resident NK Cells in Colorectal Liver Metastasis , 2018, Cancer Immunology Research.
[24] R. Verhaak,et al. EGFR heterogeneity and implications for therapeutic intervention in glioblastoma , 2018, Neuro-oncology.
[25] J. Cho,et al. Functional role of ginseng-derived compounds in cancer , 2017, Journal of ginseng research.
[26] Wenfeng Li,et al. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[27] C. Mancuso,et al. Panax ginseng and Panax quinquefolius: From pharmacology to toxicology , 2017, Food and Chemical Toxicology.
[28] D. Mcclements,et al. Antitumor and immunomodulatory effects of ginsenoside Rh2 and its octyl ester derivative in H22 tumor-bearing mice , 2017 .
[29] Marie Strickland,et al. Metabolic Reprogramming in Glioma , 2017, Front. Cell Dev. Biol..
[30] D. Quail,et al. The Microenvironmental Landscape of Brain Tumors. , 2017, Cancer cell.
[31] J. Wan,et al. Anticancer Activities of Protopanaxadiol- and Protopanaxatriol-Type Ginsenosides and Their Metabolites , 2016, Evidence-based complementary and alternative medicine : eCAM.
[32] M. Helmer-Citterich,et al. c-MYC inhibition impairs hypoxia response in glioblastoma multiforme , 2016, Oncotarget.
[33] Wei Zhang,et al. Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma. , 2016, Radiology.
[34] P. Nunn,et al. The Regulation and Function of Lactate Dehydrogenase A: Therapeutic Potential in Brain Tumor , 2015, Brain pathology.
[35] Xu-Bin Wei,et al. Ginsenoside Rh2-B1 stimulates cell proliferation and IFN-γ production by activating the p38 MAPK and ERK-dependent signaling pathways in CTLL-2 cells , 2014, Immunopharmacology and immunotoxicology.
[36] Yongdong Feng,et al. c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α. , 2013, Biochemical and biophysical research communications.
[37] Alessia Ricupito,et al. Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. , 2012, Cancer research.
[38] I. Date,et al. Angiogenesis and invasion in glioma , 2011, Brain Tumor Pathology.
[39] K. Podar,et al. A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways. , 2010, Cell cycle.
[40] Forest M White,et al. Oncogenic EGFR Signaling Networks in Glioma , 2009, Science Signaling.
[41] yang-xin fu,et al. Tumor-infiltrating T lymphocytes: friends or foes? , 2006, Laboratory Investigation.
[42] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.